OxytocinHormone TherapySafety Rating 9/10
Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.
Price Comparison
Compare vendors · per 5mg
| Vendor | Price | $ / mg | Updated | |
|---|---|---|---|---|
| SomaChemsBest $/mgCOA ✓ · 3P | $39.99 | $4.00 | May 14, 2026 | Buy → |
| Biotech PeptidesCOA unknown | $45.00 | $4.50 | May 14, 2026 | Buy → |
| LeoLab RxCOA ✓ · 3P | $10.00 | $5.00 | Apr 6, 2026 | Buy → |
| Core PeptidesCOA ✓ · 3P | $52.00 | $5.20 | Apr 16, 2026 | Buy → |
| Evolve PeptidesCOA ✓ · 3P | $29.75 | $5.95 | Apr 22, 2026 | Buy → |
Overview
About Oxytocin
Mechanism of action
Endogenous nonapeptide; binds oxytocin receptors in brain and periphery; modulates social bonding, trust, and empathy; analgesic; uterotonic; reduces HPA axis (cortisol) activity.
Safety profile
Generally safe. Possible nausea, headache, hypotension. May reduce cortisol (beneficial). Overuse may blunt natural production. · Decades of use in L&D; water intoxication risk at very high doses; well-characterized
🔔 Get notified when the price drops anywhere
No account required. We scan 30+ vendors daily — one email the moment any vendor drops Oxytocin below your target.
Safety & Interactions
Contraindications & Drug Interactions
Research use only — not medical advice. Consult a licensed physician before using any peptide. Sources are cited where available.
Hypersensitivity to oxytocin.
Water intoxication and hyponatremia — risk at high doses or prolonged infusion.
Cardiovascular disease — transient BP changes reported.
Related pages
More on Oxytocin
Research
Studies & key findings
- FDA-approved as Pitocin (IV/IM) for labor induction and augmentation, and as the WHO first-line uterotonic agent (10 IU) for prevention and treatment of postpartum hemorrhage — the leading cause of maternal mortality worldwide.
- Intranasal oxytocin improved emotion recognition in a landmark double-blind, placebo-controlled crossover trial of male adolescents with ASD (Guastella et al., 2010); a 2015 Molecular Psychiatry crossover trial (31 children) showed significant social responsiveness improvements over 5 weeks.